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The authors note that the above article [1] contained some
inaccurate information. First, we have received clarifica-
tion that no pilot program for methadone maintenance is
currently planned, though there is agreement that such an
activity is needed in Afghanistan.
Second, the name of the outreach and NEP program in
Kabul is Zandagi Nawin located in the Dai Afghanan sec-
tion of the city.
Last, the current locations for counseling and prevention
activities are Kabul, Herat, Faizabad, Gardez, and Kanda-
har with Nejat Center (Kabul) and GTZ working as sepa-
rate entities. GTZ is working with NGO partners KOR in
Kabul and Faizabad, with Wadan in Gardez and Kanda-
har, and with SHRO in Herat. We apologize for any mis-
representation and thank Dr. Bayan Shairshah for
bringing this to our attention.
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